| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3235349 | Apollo Medicine | 2010 | 5 Pages |
Abstract
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for a bulk of acute and chronic liver diseases world-wide. Since, both the viruses share similar risk factors and modes of transmission, a combined HBV and HCV infection is frequently encountered especially in the HBV endemic areas. Until lately anti-HBc antibodies were considered as surrogate marker for HCV infection. But with the development of advanced tests for HCV detection the role of anti-HBc in this regard stands uncertain.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
